Prot #APL2-GA-305: A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects with Geographic Atrophy Secondary to Age-Related Macular Degeneration

Project: Research project

Project Details

StatusActive
Effective start/end date9/13/219/13/24

Funding

  • Covance Inc. (Prot #APL2-GA-305)
  • Apellis Pharmaceuticals, Inc. (Prot #APL2-GA-305)